IRAK1 and central nervous system cancer: The Kaplan-Meier survival analysis from TCGA and Rembrandt datasets, showing a worse prognosis of glioma patients with higher IRAK1 expression, further indicated the correlation of IRAK1 in glioma development (Fig. 1e, f).